IBDEI361 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50549,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,50550,0)
 ;;=Z87.442^^193^2494^84
 ;;^UTILITY(U,$J,358.3,50550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50550,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,50550,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,50550,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,50551,0)
 ;;=N18.1^^193^2494^15
 ;;^UTILITY(U,$J,358.3,50551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50551,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,50551,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,50551,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,50552,0)
 ;;=N18.2^^193^2494^16
 ;;^UTILITY(U,$J,358.3,50552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50552,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,50552,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,50552,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,50553,0)
 ;;=N18.3^^193^2494^17
 ;;^UTILITY(U,$J,358.3,50553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50553,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,50553,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,50553,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,50554,0)
 ;;=N18.4^^193^2494^18
 ;;^UTILITY(U,$J,358.3,50554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50554,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,50554,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,50554,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,50555,0)
 ;;=N18.5^^193^2494^19
 ;;^UTILITY(U,$J,358.3,50555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50555,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,50555,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,50555,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,50556,0)
 ;;=Q61.3^^193^2494^87
 ;;^UTILITY(U,$J,358.3,50556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50556,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,50556,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,50556,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,50557,0)
 ;;=N20.1^^193^2494^11
 ;;^UTILITY(U,$J,358.3,50557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50557,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,50557,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,50557,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,50558,0)
 ;;=N18.9^^193^2494^20
 ;;^UTILITY(U,$J,358.3,50558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50558,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,50558,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,50558,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,50559,0)
 ;;=N18.6^^193^2494^30
 ;;^UTILITY(U,$J,358.3,50559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50559,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,50559,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,50559,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,50560,0)
 ;;=N52.9^^193^2494^47
 ;;^UTILITY(U,$J,358.3,50560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50560,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,50560,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,50560,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,50561,0)
 ;;=N32.81^^193^2494^82
 ;;^UTILITY(U,$J,358.3,50561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50561,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,50561,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,50561,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,50562,0)
 ;;=Q61.2^^193^2494^86
 ;;^UTILITY(U,$J,358.3,50562,1,0)
 ;;=^358.31IA^4^2
